View in EDS HTML Full Text PDF Full Text

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.

Saved in:
Bibliographic Details
Title: Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.
Authors: Jones D; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia., Whitehead CA; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia., Dinevska M; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia., Widodo SS; Department of Microbiology and Immunology, School of Biomedical Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia., Furst LM; Department of Microbiology and Immunology, School of Biomedical Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia., Morokoff AP; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.; Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia., Kaye AH; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.; Hadassah University Medical Centre, 91120, Jerusalem, Israel., Drummond KJ; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.; Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia., Mantamadiotis T; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.; Department of Microbiology and Immunology, School of Biomedical Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia., Stylli SS; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia. stanley.stylli@mh.org.au.; Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia. stanley.stylli@mh.org.au.
Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2023 Jun; Vol. 478 (6), pp. 1251-1267. Date of Electronic Publication: 2022 Oct 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4919 (Electronic) Linking ISSN: 03008177 NLM ISO Abbreviation: Mol Cell Biochem Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36302993
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jones+D%22">Jones D</searchLink>; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.<br /><searchLink fieldCode="AU" term="%22Whitehead+CA%22">Whitehead CA</searchLink>; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.<br /><searchLink fieldCode="AU" term="%22Dinevska+M%22">Dinevska M</searchLink>; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.<br /><searchLink fieldCode="AU" term="%22Widodo+SS%22">Widodo SS</searchLink>; Department of Microbiology and Immunology, School of Biomedical Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Furst+LM%22">Furst LM</searchLink>; Department of Microbiology and Immunology, School of Biomedical Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Morokoff+AP%22">Morokoff AP</searchLink>; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.; Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.<br /><searchLink fieldCode="AU" term="%22Kaye+AH%22">Kaye AH</searchLink>; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.; Hadassah University Medical Centre, 91120, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Drummond+KJ%22">Drummond KJ</searchLink>; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.; Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.<br /><searchLink fieldCode="AU" term="%22Mantamadiotis+T%22">Mantamadiotis T</searchLink>; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.; Department of Microbiology and Immunology, School of Biomedical Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Stylli+SS%22">Stylli SS</searchLink>; Level 5, Clinical Sciences Building, Department of Surgery, The University of Melbourne, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia. stanley.stylli@mh.org.au.; Department of Neurosurgery, The Royal Melbourne Hospital, Parkville, VIC, 3050, Australia. stanley.stylli@mh.org.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220364456%22">Molecular and cellular biochemistry</searchLink> [Mol Cell Biochem] 2023 Jun; Vol. 478 (6), pp. 1251-1267. <i>Date of Electronic Publication: </i>2022 Oct 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0364456 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-4919 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203008177%22">03008177 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cell Biochem <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36302993
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11010-022-04584-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1251
    Titles:
      – TitleFull: Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jones D
      – PersonEntity:
          Name:
            NameFull: Whitehead CA
      – PersonEntity:
          Name:
            NameFull: Dinevska M
      – PersonEntity:
          Name:
            NameFull: Widodo SS
      – PersonEntity:
          Name:
            NameFull: Furst LM
      – PersonEntity:
          Name:
            NameFull: Morokoff AP
      – PersonEntity:
          Name:
            NameFull: Kaye AH
      – PersonEntity:
          Name:
            NameFull: Drummond KJ
      – PersonEntity:
          Name:
            NameFull: Mantamadiotis T
      – PersonEntity:
          Name:
            NameFull: Stylli SS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2023 Jun
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1573-4919
          Numbering:
            – Type: volume
              Value: 478
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Molecular and cellular biochemistry
              Type: main
ResultId 1